PREVENTION OF ACUTE AND CHRONIC LIVER-DISEASE THROUGH IMMUNIZATION - HEPATITIS-B AND BEYOND

被引:50
作者
MARGOLIS, HS
机构
[1] Hepatitis Branch (World Health Organization Collaborating Centre for Research and Reference in Viral Hepatitis), Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Atlanta
关键词
D O I
10.1093/infdis/168.1.9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liver disease caused by hepatotrophic viruses imposes a substantial burden on health care resources. Persistent infections from hepatitis B virus (HBV), hepatitis C virus, and hepatitis delta virus result in chronic liver disease, while hepatitis A virus and hepatitis E virus produce a self-limited disease. Effective hepatitis B vaccines that provide long-term protection against chronic HBV infection have been available for > 10 years, while inactivated hepatitis A vaccines have recently been shown to prevent acute disease. To prevent transmission of HBV, scientifically and epidemiologically sound recommendations call for vaccination of all infants in successive birth cohorts worldwide. For hepatitis A vaccines, recommendations will be developed in the near future and should reflect vaccine performance and the epidemiology of hepatitis A. A number of policy, health care financing, and educational issues must be addressed to ensure the effective use of both of these vaccines.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 56 条
  • [21] HENDERSON RH, 1984, PROTECTING WORLDS CH, P17
  • [22] HEPATITIS-A IN THE UNITED-STATES-ARMY - EPIDEMIOLOGY AND VACCINE DEVELOPMENT
    HOKE, CH
    BINN, LN
    EGAN, JE
    DEFRAITES, RF
    MACARTHY, PO
    INNIS, BL
    ECKELS, KH
    DUBOIS, D
    DHONDT, E
    SJOGREN, MH
    RICE, R
    SADOFF, JC
    BANCROFT, WH
    [J]. VACCINE, 1992, 10 : S75 - S79
  • [23] HURIE MB, 1992, PEDIATRICS, V89, P269
  • [24] HWANG LY, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P759
  • [25] FIELD EFFICACY TRIAL OF INACTIVATED HEPATITIS-A VACCINE AMONG CHILDREN IN THAILAND
    INNIS, BL
    SNITBHAN, R
    KUNASOL, P
    LAORAKPONGSE, T
    POOPATANAKOOL, W
    SUNTAYAKORN, S
    SUKNANTAPONG, T
    SAFARY, A
    BOSLEGO, JW
    [J]. VACCINE, 1992, 10 : S159 - S159
  • [26] JOHNSON K, 1988, 22ND P IMM C ATL, P43
  • [27] SIMULTANEOUS PASSIVE AND ACTIVE IMMUNIZATION AGAINST HEPATITIS-A
    LEENTVAARKUIJPERS, A
    COUTINHO, RA
    BRULEIN, V
    SAFARY, A
    [J]. VACCINE, 1992, 10 : S138 - S141
  • [28] LEWIS M, 1992, PEDIATRICS, V90, P771
  • [29] LONG-TERM IMMUNOGENICITY AND EFFICACY OF HEPATITIS-B VACCINE IN INFANTS BORN TO HBEAG-POSITIVE HBSAG-CARRIER MOTHERS
    LO, KJ
    LEE, SD
    TSAI, YT
    WU, TC
    CHAN, CY
    CHEN, GH
    YEH, CL
    [J]. HEPATOLOGY, 1988, 8 (06) : 1647 - 1650
  • [30] PRIMARY STUDY OF ATTENUATED LIVE HEPATITIS-A VACCINE (H2 STRAIN) IN HUMANS
    MAO, JS
    DONG, DX
    ZHANG, HY
    CHEN, NL
    ZHANG, XY
    HUANG, HY
    XIE, RY
    ZHOU, TJ
    WAN, ZJ
    WANG, YZ
    HU, ZH
    CAO, YY
    LI, HM
    CHU, CM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) : 621 - 624